Vaxil Bio Ltd. (TSXV:VXL)

Vaxil Bio Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 5, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Cap	1	1	1	3	3	10
Market Cap Growth	-48.62%	-57.83%	-60.00%	25.00%	-73.33%	-71.18%
Enterprise Value	0.38	-0.09	0.92	2.49	1.23	8.03
Last Close Price	0.27	0.14	0.50	1.25	1.00	3.75
PE Ratio	1.44	0.79	-10.00	-12.50	-2.00	-7.50
PB Ratio	0.77	0.42	1.91	3.84	2.41	6.04
P/TBV Ratio	0.55	0.30	1.91	3.84	2.41	6.01
P/FCF Ratio	-	-3.66	-7.29	-6.10	-3.73	-9.48
P/OCF Ratio	-	-3.66	-7.29	-6.10	-3.73	-9.48
EV/EBITDA Ratio	-	0.52	-6.23	-9.79	-2.11	-8.36
EV/EBIT Ratio	-	0.52	-6.23	-9.79	-2.11	-8.15
EV/FCF Ratio	-	0.59	-4.90	-4.43	-1.68	-7.41
Net Debt / Equity Ratio	-0.49	-0.49	-0.63	-1.05	-1.33	-1.32
Net Debt / EBITDA Ratio	3.59	3.75	3.03	3.69	2.60	2.33
Net Debt / FCF Ratio	5.50	4.25	2.38	1.67	2.06	2.07
Quick Ratio	137.00	137.00	43.12	11.48	3.80	3.90
Current Ratio	137.00	137.00	43.12	11.48	3.80	3.90
Return on Equity (ROE)	-9.61%	50.07%	-16.18%	-25.06%	-41.18%	-78.75%
Return on Assets (ROA)	-17.78%	-17.02%	-17.32%	-20.18%	-30.53%	-49.97%
Return on Invested Capital (ROIC)	-38.88%	-37.21%	-133.94%	120.67%	127.65%	201.64%
Return on Capital Employed (ROCE)	-17.97%	-17.20%	-18.42%	-25.06%	-41.18%	-78.75%
Earnings Yield	49.44%	126.90%	-10.00%	-8.00%	-50.00%	-13.33%
FCF Yield	-	-27.35%	-13.72%	-16.38%	-26.79%	-10.55%
Buyback Yield / Dilution	-3.48%	-3.48%	0.00%	0.00%	-0.64%	-33.78%
Total Shareholder Return	-3.48%	-3.48%	0.00%	0.00%	-0.64%	-33.78%

Updated May 1, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.